These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16975)

  • 41. Inverse relationship between ristocetin co-factor levels and platelet aggregation in insulin dependent diabetes.
    Porta M; McCraw A; Kohner EM
    Thromb Res; 1982 Mar; 25(6):507-12. PubMed ID: 6981229
    [No Abstract]   [Full Text] [Related]  

  • 42. Willebrand factor in von Willebrand's disease.
    Boulton FE; Lloyd MJ
    Br Med J; 1975 Nov; 4(5993):384. PubMed ID: 1081419
    [No Abstract]   [Full Text] [Related]  

  • 43. Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in renal failure.
    Warrell RP; Hultin MB; Coller BS
    Am J Med; 1979 Feb; 66(2):226-8. PubMed ID: 311586
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibitory effect of ristocetin and factor VIII/von Willebrand factor protein on human platelet adenylate cyclase activity.
    Kao KJ; Tsai BS; McKee PA; Lefkowitz RJ; Pizzo SV
    Thromb Res; 1983 May; 30(3):301-8. PubMed ID: 6408756
    [No Abstract]   [Full Text] [Related]  

  • 45. A critical evaluation of the available methods for the determination of factor VIII von Willebrand.
    Casonato A; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):670-84. PubMed ID: 2435633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
    Ruggeri ZM; Zimmerman TS
    J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Factor VIII/von Willebrand factor complex (FVIII/vWF)].
    Yoshioka A
    Rinsho Byori; 1985 Feb; Spec No 61():73-85. PubMed ID: 3923232
    [No Abstract]   [Full Text] [Related]  

  • 48. Factor VIII related activities in concentrates.
    Nilsson IM; Borge L; Gunnarsson M; Kristoffersson AC
    Scand J Haematol Suppl; 1984; 41():157-72. PubMed ID: 6440282
    [No Abstract]   [Full Text] [Related]  

  • 49. Von Willebrand factor dependent platelet aggregation and adsorption of factor VIII related antigen by collagen.
    Nyman D
    Thromb Res; 1980 Jan 1-15; 17(1-2):209-14. PubMed ID: 6154982
    [No Abstract]   [Full Text] [Related]  

  • 50. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
    Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
    J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Von Willebrand disease--a variation with an aberrant multimeric structure].
    Batlle Fonrodona J; López Fernández MF; Fernández Villamor A; López Berges C; Lasierra Cirujeda J; López Borrasca A
    Sangre (Barc); 1985; 30(2):146-53. PubMed ID: 3925572
    [No Abstract]   [Full Text] [Related]  

  • 52. Von Willebrand factor: dissociation from antihemophilic factor procoagulant activity.
    Weiss HJ; Hoyer IW
    Science; 1973 Dec; 182(4117):1149-51. PubMed ID: 4127287
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factor VIII-von Willebrand factor in giant cell arteritis and polymyalgia rheumatica.
    Persellin ST; Daniels TM; Rings LJ; Kazmier FJ; Bowie EJ; Hunder GG
    Mayo Clin Proc; 1985 Jul; 60(7):457-62. PubMed ID: 3925247
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Willebrand factor and ristocetin. I. Mechanism of rustocetin-induced platelet aggregation.
    Jenkins CS; Meyer D; Dreyfus MD; Larrieu MJ
    Br J Haematol; 1974 Dec; 28(4):561-78. PubMed ID: 4141901
    [No Abstract]   [Full Text] [Related]  

  • 55. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnosis and classification of von Willebrand disease: a review of the differential utility of various functional von Willebrand factor assays.
    Favaloro EJ
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):553-64. PubMed ID: 21885953
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Recent findings on ristocetin in the field of biochemistry].
    Nakamura H; Abe T
    Nihon Rinsho; 1981; 39(12):3643-6. PubMed ID: 6803030
    [No Abstract]   [Full Text] [Related]  

  • 58. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
    Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA
    Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The in vitro association of antihemophilic factor and von Willebrand factor.
    Zucker MB; Soberano ME; Johnson AJ; Fulton AJ; Kowalski S; Adler M
    Thromb Haemost; 1983 Feb; 49(1):37-41. PubMed ID: 6405497
    [No Abstract]   [Full Text] [Related]  

  • 60. Potential supplementary utility of combined PFA-100 and functional von Willebrand factor testing for the laboratory assessment of desmopressin and factor concentrate therapy in von Willebrand disease.
    Favaloro EJ; Thom J; Patterson D; Just S; Baccala M; Dixon T; Meiring M; Koutts J; Rowell J; Baker R
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):475-83. PubMed ID: 19584715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.